We first examined genomic DNAs from 217 tumors for mutations in a set of core genes previously reported to harbor mutations in NSCLC, i.e. in EGFR, HER2, HER4, KRAS, PIK3CA, and BRAF(Figure 1). This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.